FN2 Earnings Intelligence
The Travelers Companies, Inc. financials
The Travelers Companies, Inc. (TRV) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $761 | $799 | $650 | $699 | $842 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $34,816 | $36,884 | $41,364 | $46,423 | $48,828 | $43,944.5 | $45,239.3 |
| % Growth | 8.9% | 5.9% | 12.1% | 12.2% | 5.2% | -10.0% | 2.9% |
| Gross Profit | $4,458 | $3,354 | $3,371 | $6,180 | $7,796 | - | - |
| % Margin | 12.8% | 9.1% | 8.1% | 13.3% | 16.0% | - | - |
| EBITDA | - | - | - | - | - | - | - |
| % Margin | - | - | - | - | - | - | - |
| Net Income | $3,662 | $2,842 | $2,991 | $4,999 | $6,288 | - | - |
| % Margin | 10.5% | 7.7% | 7.2% | 10.8% | 12.9% | - | - |
| Diluted EPS | $14.49 | $11.77 | $12.79 | $21.47 | $27.43 | $33.87 | $30.17 |
| % Growth | 37.7% | -18.8% | 8.7% | 67.9% | 27.8% | 23.5% | -10.9% |
| Operating Cash Flow | $7,274 | $6,465 | $7,711 | $9,074 | $10,606 | - | - |
| CapEx | - | - | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $34,816 | $36,884 | $41,364 | $46,423 | $48,828 | $43,944.5 | $45,239.3 |
| Gross Profit | $4,458 | $3,354 | $3,371 | $6,180 | $7,796 | - | - |
| EBITDA | - | - | - | - | - | - | - |
| Net Income | $3,662 | $2,842 | $2,991 | $4,999 | $6,288 | - | - |
| Diluted EPS | $14.49 | $11.77 | $12.79 | $21.47 | $27.43 | $33.87 | $30.17 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $761 | $799 | $650 | $699 | $842 |
| Short-term Debt | $100 | $100 | $100 | $100 | $300 |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $7,274 | $6,465 | $7,711 | $9,074 | $10,606 |
| Capital Expenditure | - | - | - | - | - |
| Free Cash Flow | - | - | - | - | - |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 8.9% | 5.9% | 12.1% | 12.2% | 5.2% |
| Gross Margin | 12.8% | 9.1% | 8.1% | 13.3% | 16.0% |
| EBITDA Margin | - | - | - | - | - |
| Net Margin | 10.5% | 7.7% | 7.2% | 10.8% | 12.9% |
| FCF Margin | - | - | - | - | - |
| Diluted EPS Growth | 37.7% | -18.8% | 8.7% | 67.9% | 27.8% |